These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6628156)

  • 1. Factors XI and XII are low in subjects with liver disease.
    Walker IR; Milner RA; Johnston MA; Rand CA; Neame PB; Hirsh J
    Dig Dis Sci; 1983 Nov; 28(11):967-70. PubMed ID: 6628156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Actin FS and Actin FSL sensitivity to specific clotting factor deficiencies.
    Lawrie AS; Kitchen S; Purdy G; Mackie IJ; Preston FE; Machin SJ
    Clin Lab Haematol; 1998 Jun; 20(3):179-86. PubMed ID: 9681235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Measurements of the activity of the coagulation factors VIII:C, IX,XI, and XII in cats].
    Mischke R; Deniz A; Nolte I
    Zentralbl Veterinarmed A; 1995 Oct; 42(8):513-20. PubMed ID: 8592897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the KC10 semi-automatic modular clot detection device].
    Crespo B; Ankri A; Lesty C
    Nouv Rev Fr Hematol (1978); 1983; 25(2):113-21. PubMed ID: 6408609
    [No Abstract]   [Full Text] [Related]  

  • 5. [Contact factors (factor XII and XI)--how to read its figures].
    Matsuoka M; Ito M
    Nihon Rinsho; 1971 Jan; 29():Suppl:624-8. PubMed ID: 4928293
    [No Abstract]   [Full Text] [Related]  

  • 6. Prolongation of the activated partial thromboplastin time associated with poor venipuncture technic.
    McPhedran P; Clyne LP; Ortoli NA; Gagnon PG; Sanders FJ
    Am J Clin Pathol; 1974 Jul; 62(1):16-20. PubMed ID: 4833734
    [No Abstract]   [Full Text] [Related]  

  • 7. Determination of the minimal concentrations of contact activation factors in deficient substrate plasmas required to assess accurately factor XII, factor XI, factor IX, and high molecular weight kininogen.
    Munakata M; Teraoka A; Komiyama Y; Masuda M; Murakami T; Murata K
    Thromb Res; 1990 Jan; 57(2):197-203. PubMed ID: 2315884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The activity of the contact substance in thromboplastin formation in the premature infant].
    Schettini F; Violante N; Lattanzi E; Mautone A
    Boll Soc Ital Biol Sper; 1966 Aug; 42(16):1060-3. PubMed ID: 5969469
    [No Abstract]   [Full Text] [Related]  

  • 9. [Activity of the contact substance in thromboplastin formation in the full-term newborn infant].
    Schettini F; Wierdis T; Lattanzi E; Violante N; Zimbalatti F
    Boll Soc Ital Biol Sper; 1966 Aug; 42(16):1058-60. PubMed ID: 5969468
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical and experimental studies on the contact factor. I. Contact factor activity in various dieases].
    Ito M
    Nihon Ketsueki Gakkai Zasshi; 1968 Dec; 31(7):1142-54. PubMed ID: 5753795
    [No Abstract]   [Full Text] [Related]  

  • 11. The relation of 'Fletcher Factor' to factors XI and XII.
    Hathaway WE; Alsever J
    Br J Haematol; 1970 Feb; 18(2):161-9. PubMed ID: 5439523
    [No Abstract]   [Full Text] [Related]  

  • 12. Rapid loss of factor XII and XI activity in ellagic acid-activated normal plasma: role of plasma inhibitors and implications for automated activated partial thromboplastin time recording.
    Joist JH; Cowan JF; Khan M
    J Lab Clin Med; 1977 Dec; 90(6):1054-65. PubMed ID: 303667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identity of contact activation cofactor and Fitzgerald factor.
    Schiffman S; Lee P; Waldmann R
    Thromb Res; 1975 May; 6(5):451-4. PubMed ID: 237340
    [No Abstract]   [Full Text] [Related]  

  • 14. A serial study of coagulation factors XII, XI and X in plasma in normal pregnancy and in pregnancy complicated by pre-eclampsia.
    Condie RG
    Br J Obstet Gynaecol; 1976 Aug; 83(8):636-9. PubMed ID: 952795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of procoagulants produced in cell cultures by tests of coagulation.
    Zacharski LR; McIntyre OR
    Thromb Diath Haemorrh; 1971 Dec; 26(3):493-502. PubMed ID: 5144962
    [No Abstract]   [Full Text] [Related]  

  • 16. [Examination of the plasma clotting activities--determination of contact factors XII, XI].
    Murakami M; Umeda T
    Rinsho Byori; 1969; 16():Suppl 16:66-74. PubMed ID: 5391587
    [No Abstract]   [Full Text] [Related]  

  • 17. A simple screening test for evaluating prolonged partial thromboplastin times in newborn infants.
    Andrew M; Karpatkin M
    J Pediatr; 1982 Oct; 101(4):610-2. PubMed ID: 7119968
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on contact factors. II. Contact activities in various diseases].
    Umeda T
    Nihon Ketsueki Gakkai Zasshi; 1968 Dec; 31(7):1173-9. PubMed ID: 5753798
    [No Abstract]   [Full Text] [Related]  

  • 19. Intrinsic clotting factors in dependency of age, sex, body mass index, and oral contraceptives: definition and risk of elevated clotting factor levels.
    Luxembourg B; Schmitt J; Humpich M; Glowatzki M; Seifried E; Lindhoff-Last E
    Blood Coagul Fibrinolysis; 2009 Oct; 20(7):524-34. PubMed ID: 19620844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific coagulation factor adsorption as related to functional groups on surfaces.
    Oja PD; Holmes GW; Perkins HA; Love J
    J Biomed Mater Res; 1969 Mar; 3(1):165-74. PubMed ID: 5784962
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.